Stimulus functions of caffeine in humans: Relation to dependence potential
暂无分享,去创建一个
[1] J. Rose. Cigarette smoking blocks caffeine-induced arousal. , 1987, Alcohol and drug research.
[2] J. Greden,et al. Caffeine-withdrawal headache: a clinical profile. , 1980, Psychosomatics.
[3] J. Henningfield,et al. Human abuse liability assessment by measurement of subjective and physiological effects. , 1989, NIDA research monograph.
[4] W K Bickel,et al. Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. , 1991, Archives of general psychiatry.
[5] J T Rainey. Headache related to chronic caffeine addiction. , 1985, Texas dental journal.
[6] S. Heishman,et al. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure. , 1989, The Journal of pharmacology and experimental therapeutics.
[7] T. Thompson,et al. Predicting dependence liability of stimulant and depressant drugs , 1977 .
[8] N. Back,et al. Modern methods in pharmacology , 1982 .
[9] F. Hoffmeister,et al. Self-administration of acetylsalicylic acid and combinations with codeine and caffeine in rhesus monkeys. , 1973, The Journal of pharmacology and experimental therapeutics.
[10] B K Tang,et al. Variability in caffeine metabolism , 1983, Clinical pharmacology and therapeutics.
[11] Winstead Dk,et al. Coffee consumption among psychiatric inpatients. , 1976 .
[12] J. Griffith. Amphetamine Dependence; Clinical Features , 1977 .
[13] M. Jc. An overview: maternal nicotine and caffeine consumption and offspring outcome. , 1982 .
[14] J. E. James,et al. Caffeine: a survey of some of the known and suspected deleterious effects of habitual use. , 1983, British journal of addiction.
[15] G. Edwards,et al. Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. , 1981, Bulletin of the World Health Organization.
[16] K. Preston,et al. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline. , 1987, The Journal of pharmacology and experimental therapeutics.
[17] J. Sours,et al. Case reports of anorexia nervosa and caffeinism. , 1983, The American journal of psychiatry.
[18] P. Gupta,et al. Caffeine: a new look at an age-old drug. , 1988, International journal of clinical pharmacology, therapy, and toxicology.
[19] D. Charney,et al. The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans. , 1984, Life sciences.
[20] R. Griffiths,et al. Opioids: Similarity between evaluations of subjective effects and animal self‐administration results , 1979, Clinical pharmacology and therapeutics.
[21] A. Goldstein,et al. PSYCHOTROPIC EFFECTS OF CAFFEINE IN MAN. I. INDIVIDUAL DIFFERENCES IN SENSITIVITY TO CAFFEINE-INDUCED WAKEFULNESS. , 1965, The Journal of pharmacology and experimental therapeutics.
[22] J. Woods,et al. Reinforcement Properties of Morphine, Cocaine, and SPA as a Function of Unit Dose , 1968 .
[23] C. Schuster,et al. Internal stimulus control and subjective effects of drugs. , 1981, NIDA research monograph.
[24] N. Benowitz,et al. Clinical pharmacology of caffeine. , 1990, Annual review of medicine.
[25] R. S. Da Silva,et al. Caffeine , 1984, Springer Berlin Heidelberg.
[26] P. Rozin,et al. Some aspects of the liking for hot coffee and coffee flavor , 1982, Appetite.
[27] J. Garriott,et al. Five cases of fatal overdose from caffeine-containing "look-alike" drugs. , 1985, Journal of analytical toxicology.
[28] Roland R. Griffiths,et al. Interactions of diazepam and caffeine: Behavioral and subjective dose effects in humans , 1987, Pharmacology Biochemistry and Behavior.
[29] H. de Wit,et al. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. , 1986, Drug and alcohol dependence.
[30] W. Watson,et al. Caffeine withdrawal symptoms. , 1987, American Journal of Emergency Medicine.
[31] A. Goldstein,et al. Psychotropic effects of caffeine in man. III. A questionnaire survey of coffee drinking and its effects in a group of housewives , 1969, Clinical pharmacology and therapeutics.
[32] K. Gilliland,et al. Caffeine: a potential drug of abuse. , 1984, Advances in alcohol & substance abuse.
[33] R. M. Elliott,et al. Behavior of Organisms , 1991 .
[34] R. Griffiths,et al. Low-dose caffeine physical dependence in humans. , 1990, The Journal of pharmacology and experimental therapeutics.
[35] M. Lader,et al. The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. , 1986, British journal of clinical pharmacology.
[36] A. Goldstein,et al. Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee , 1969, Clinical pharmacology and therapeutics.
[37] R. Griffiths,et al. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. , 1986, The Journal of pharmacology and experimental therapeutics.
[38] Rainey Jt. Headache related to chronic caffeine addiction. , 1985 .
[39] R. Griffiths,et al. Relative abuse liability of triazolam: Experimental assessment in animals and humans , 1985, Neuroscience & Biobehavioral Reviews.
[40] J. Greden,et al. Anxiety and depression associated with caffeinism among psychiatric inpatients. , 1978, The American journal of psychiatry.
[41] S. Evans,et al. Amphetamine-like effects of anorectics and related compounds in pigeons. , 1987, The Journal of pharmacology and experimental therapeutics.
[42] T. Rall. Drugs used in the treatment of asthma , 1990 .
[43] H. Cappell,et al. Tolerance and Physical Dependence , 1981 .
[44] C. Haertzen. An Overview of Addiction Research Center Inventory Scales (ARCI): An Appendix and Manual of Scales. , 1974 .
[45] M. Mattila,et al. Caffeine and theophylline counteract diazepam effects in man. , 1983, Medical biology.
[46] M. Enslen,et al. Self-administration of caffeine by the rat. , 1976, Arzneimittel-Forschung.
[47] E. O. O. Smoking. "The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General" (Title Page through Table of Contents) , 1988 .
[48] R. Griffiths,et al. Effects of caffeine on cigarette smoking and subjective response , 1983, Clinical pharmacology and therapeutics.
[49] J. Henningfield,et al. Abuse liability assessment in human subjects , 1984 .
[50] R. LaBrie,et al. Assessing the subjective effects of stimulants in casual users; A methodology and preliminary results , 1978, Clinical pharmacology and therapeutics.
[51] E. Uhlenhuth,et al. Drug preference and mood in humans: Repeated assessment of d-amphetamine , 1981, Pharmacology Biochemistry and Behavior.
[52] S. File,et al. Behavioral effects of acute and chronic administration of caffeine in the rat , 1988, Pharmacology Biochemistry and Behavior.
[53] Myung Cw,et al. Drug addiction and drug abuse in Korea. , 1974 .
[54] W. Martin,et al. Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test. , 1961, The Journal of pharmacology and experimental therapeutics.
[55] R. Smith,et al. CAFFEINE WITHDRAWAL HEADACHE , 1976, Journal of clinical pharmacy and therapeutics.
[56] L. Kozlowski,et al. Effect of caffeine on coffee drinking , 1976, Nature.
[57] J. Brady,et al. Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc. , 1984, NIDA research monograph.
[58] S. Heishman,et al. Discriminative stimulus effects of d-amphetamine, methylphenidate and diazepam in humans , 1989, Pharmacology Biochemistry and Behavior.
[59] Stephen G. Holtzman,et al. Tolerance to behavioral effects of caffeine in rats , 1988, Pharmacology Biochemistry and Behavior.
[60] P. Rozin,et al. Conditioned opponent responses in human tolerance to caffeine , 1984 .
[61] P. Morrow. Caffeine toxicity: a case of child abuse by drug ingestion. , 1987, Journal of forensic sciences.
[62] D. Jasinski,et al. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man , 1971, Clinical pharmacology and therapeutics.
[63] R. Notari,et al. Predicting Caffeine Plasma Concentrations Resulting from Consumption of Food or Beverages: A Simple Method and its Origin , 1988, Drug intelligence & clinical pharmacy.
[64] D. Jasinski,et al. Assessment of the Abuse Potentiality of Morphinelike Drugs (Methods Used in Man) , 1977 .
[65] N. Russ,et al. Abuse of caffeine in substance abusers. , 1988, The Journal of clinical psychiatry.
[66] M B Katan,et al. Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. , 1990, BMJ.
[67] D. Galletly,et al. DOES CAFFEINE WITHDRAWAL CONTRIBUTE TO POSTANAESTHETIC MORBIDITY? , 1989, The Lancet.
[68] Miller Jl. Caffeine, chocolate and withdrawal headaches. , 1960 .
[69] S. Woods,et al. Caffeine: Preferential consumption by rats , 1975, Pharmacology Biochemistry and Behavior.
[70] J. Brady,et al. Stimulus functions of drugs and the assessment of abuse liability , 1990 .
[71] J. Brady,et al. Instrumental Conditioning of Jugular Self-Infusion in the Rhesus Monkey , 1961, Science.
[72] J. J. Barone,et al. Human Consumption of Caffeine , 1984 .
[73] L. Roller,et al. CAFFEINISM: SUBJECTIVE QUANTITATIVE ASPECT OF WITHDRAWAL SYNDROME , 1981, The Medical journal of Australia.
[74] A. Goldstein,et al. Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood. , 1965, The Journal of pharmacology and experimental therapeutics.
[75] A. W. Downs,et al. TOLERANCE AND CROSS-TOLERANCE IN THE HUMAN SUBJECT TO THE DIURETIC EFFECT OF CAFFEINE, THEOBROMINE AND THEOPHYLLINE , 1928 .
[76] L. Saxén,et al. Coffee consumption during pregnancy and selected congenital malformations: a nationwide case-control study. , 1983, American journal of public health.
[77] K. Bättig,et al. The Physiological Effects of Coffee Consumption , 1985 .
[78] J K Wilkin,et al. The caffeine withdrawal flush: report of a case of "weekend flushing". , 1986, Military medicine.
[79] J. Crosbie,et al. Somatic and psychological health implications of heavy caffeine use. , 1987, British journal of addiction.
[80] G. Spiller. The Methylxanthine beverages and foods : chemistry, consumption, and health effects , 1984 .
[81] H. Lieberman,et al. The Effects of Caffeine and Aspirin on Mood and Performance , 1987, Journal of clinical psychopharmacology.
[82] W. Taylor,et al. CARBENOXOLONE AND GASTRIC SECRETION , 1975, The Lancet.
[83] Roland R. Griffiths,et al. Reinforcing effects of caffeine in humans , 1988, Pharmacology Biochemistry and Behavior.
[84] S J Heishman,et al. Low-dose caffeine discrimination in humans. , 1990, The Journal of pharmacology and experimental therapeutics.
[85] A. Winsor,et al. A study of the development of tolerance for caffeinated beverages. , 1933 .
[86] J. R. Weeks,et al. Experimental Morphine Addiction: Method for Automatic Intravenous Injections in Unrestrained Rats , 1962, Science.
[87] Podboy Jw,et al. Caffeine reduction and behavior change in the severely retarded. , 1977 .
[88] D. Kirmer. Caffeine use and abuse in psychiatric clients. , 1988, Journal of psychosocial nursing and mental health services.
[89] R. Foxx,et al. Behavioral treatment of caffeinism: reducing excessive coffee drinking. , 1979, Journal of applied behavior analysis.
[90] R R Watson,et al. The effects of caffeine on various body systems: a review. , 1987, Journal of the American Dietetic Association.
[91] E. D. Kemble,et al. Effects of food deprivation on caffeine consumption in male and female rats , 1986, Pharmacology Biochemistry and Behavior.
[92] Susan J Wells,et al. Caffeine: implications of recent research for clinical practice. , 1984, The American journal of orthopsychiatry.
[93] S. Higgins,et al. A Comment on Contemporary Definitions of Reinforcement as a Behavioral Process , 1985 .
[94] I. Syed,et al. The effects of caffeine. , 1976, Journal of the American Pharmaceutical Association.
[95] J W Podboy,et al. Caffeine reduction and behavior change in the severely retarded. , 1977, Mental retardation.
[96] D Robertson,et al. The health consequences of caffeine. , 1983, Annals of internal medicine.
[97] M G Myers,et al. Effects of caffeine on blood pressure. , 1988, Archives of internal medicine.
[98] D. Overton. Applications and Limitations of the Drug Discrimination Method for the Study Of Drug Abuse , 1987 .
[99] J L Katz,et al. Abuse liability of benzodiazepines. , 1987, Pharmacological reviews.
[100] K. Unna,et al. Effects of chronic administration of the amphetamines and other stimulants on behavior , 1968, Clinical pharmacology and therapeutics.
[101] James T. Kuznicki,et al. The effects of caffeine on caffeine users and non-users , 1986, Physiology & Behavior.
[102] Michael A. Bozarth. Methods of assessing the reinforcing properties of abused drugs , 1987 .
[103] S. Holtzman. Caffeine as a model drug of abuse. , 1990, Trends in pharmacological sciences.
[104] P. Ruiz,et al. Substance abuse : clinical problems and perspectives , 1982 .
[105] B. Skinner,et al. Science and human behavior , 1953 .
[106] P. B. Dews,et al. Behavioral effects of caffeine , 2020, Caffeine and Behavior: Current Views & Research Trends.
[107] C. Haertzen,et al. Addiction Research Center Inventory (ARCI): Measurement of Euphoria and Other Drug Effects , 1987 .
[108] J. Carney,et al. EFFECTS OF CAFFEINE, THEOPHYLLINE AND THEOBROMINE ON SCHEDULED CONTROLLED RESPONDING IN RATS , 1982, British journal of pharmacology.
[109] J. McGowan,et al. Neonatal Withdrawal Symptoms After Chronic Maternal Ingestion of Caffeine , 1988, Southern medical journal.
[110] R Workman,et al. Tolerance to the humoral and hemodynamic effects of caffeine in man. , 1981, The Journal of clinical investigation.
[111] K. Preston,et al. Subjective and discriminative effects of drugs. , 1991, Behavioural pharmacology.
[112] H. Kalant,et al. Drug policy: striking the right balance. , 1990, Science.
[113] R. Griffiths,et al. Predicting the Abuse Liability of Drugs with Animal Drug Self-Administration Procedures: Psychomotor Stimulants and Hallucinogens , 1979 .
[114] J. Greden,et al. Somatic manifestations of caffeinism. , 1981, The Journal of clinical psychiatry.
[115] Roland R. Griffiths,et al. Reinforcing properties of caffeine: Studies in humans and laboratory animals , 1988, Pharmacology Biochemistry and Behavior.
[116] F. Holloway,et al. Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue. , 1985, Life sciences.
[117] D E Grobbee,et al. Coffee, caffeine, and cardiovascular disease in men. , 1990, The New England journal of medicine.
[118] D. Gauvin,et al. Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue. , 1985, Life sciences.
[119] M M Callahan,et al. Comparison of caffeine metabolism in three nonsmoking populations after oral administration of radiolabeled caffeine. , 1983, Drug metabolism and disposition: the biological fate of chemicals.
[120] G. Friedman,et al. Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. , 1990, American journal of epidemiology.
[121] R. Edelmann,et al. The Effects of Caffeine on Psychological Functioning , 1985, Nutrition and health.
[122] S. File,et al. Interaction Between Effects of Caffeine and Lorazepam in Performance Tests and Self‐Ratings , 1982, Journal of clinical psychopharmacology.
[123] R. Griffiths,et al. Human coffee drinking: manipulation of concentration and caffeine dose. , 1986, Journal of the experimental analysis of behavior.
[124] A. Leviton. Caffeine consumption and the risk of reproductive hazards. , 1988, The Journal of reproductive medicine.
[125] M. Mattila,et al. Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam. , 1988, International clinical psychopharmacology.
[126] R. Griffiths,et al. Reinforcing effects of caffeine in coffee and capsules. , 1989, Journal of the experimental analysis of behavior.
[127] Jaffe Jh,et al. Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs. , 1989 .
[128] R. E. Gosselin,et al. The tolerance of coffee drinkers to caffeine , 1968, Clinical pharmacology and therapeutics.
[129] R. Noble. A Controlled Clinical Trial of the Cardiovascular and Psychological Effects of Phenylpropanolamine and Caffeine , 1988, Drug intelligence & clinical pharmacy.
[130] H. Reimann. Caffeinism. A cause of long-continued, low-grade fever. , 1967, JAMA.
[131] B. Hampton,et al. Caffeine fading: Behavioral treatment of caffeine abuse , 1985 .
[132] K Hirsh,et al. Central nervous system pharmacology of the dietary methylxanthines. , 1984, Progress in clinical and biological research.
[133] P. J. Abbott. Caffeine: a toxicological overview , 1986, The Medical journal of Australia.
[134] D. Templer,et al. Effects of caffeine on anxiety and depression. , 1984, Journal of abnormal psychology.
[135] J. Greden,et al. Anxiety or caffeinism: a diagnostic dilemma. , 1974, The American journal of psychiatry.
[136] B. Weiss,et al. Enhancement of human performance by caffeine and the amphetamines. , 1962, Pharmacological reviews.
[137] Margaret C. Mc Manamy,et al. Caffeine Intoxication: Report of a Case the Symptoms of Which Amounted to a Psychosis , 1936 .
[138] M. Fischman,et al. Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs. , 1989, NIDA research monograph.